Clinical Trial Update: Effect of N-acetylcysteine as Adjunct Therapy on the Clinical Outcome of Neonatal Sepsis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating N-acetylcysteine as adjunct therapy for neonatal sepsis; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Sepsis

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Ain Shams University | Conditions: Neonatal Sepsis | Phase 3 | Status: NOT_YET_RECRUITING